Chemomab Therapeutics (CMMB) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CMMB is expected to report earnings to fall 667.00% to -5 cents per share on March 06

Chemomab Therapeutics CMMB Stock Earnings Reports

Q4'24

Est.

$-0.06

Q3'24

Beat

by $0.07

Q2'24

Beat

by $0.09

Q1'24

Beat

by $0.03

Q4'23

Beat

by $0.03

The last earnings report on November 14 showed earnings per share of 0 cents, beating the estimate of -5 cents. With 40.23K shares outstanding, the current market capitalization sits at 31.68M.

View a ticker or compare two or three

Compare

CMMB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CMMB
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a provider of biopharmaceutical services

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

Kiryat Atidim

Phone

+972 773310156

Employees

Web

https://www.chemomab.com